Equites Radar

IRMD · iRadimed Corporation

Medical DevicesUnited StatesAnalyst view: none

$81.96

+0.12% last session

End-of-day data · close of 2026-09-11

Bearish1 bullish · 4 bearish technical signals
To mean target: +44.1%

Market cap

$1B

Enterprise value

$1B

Trailing P/E

46.5

Forward P/E

34.0

Dividend yield

1.0%

Beta

0.90

Avg volume

0M

Employees

0K

Daily Change %

0.12%

5 Days Change

0.13%

10 Days Change

-3.26%

30 Days Change

-5.83%

60 Days Change

-13.84%

Month to Day Change

-3.26%

Year to Day Change

-13.54%

Analyst Outlook

Consensus rating
Recommendation mean (1–5)
Covering analysts2
Mean price target$118.00
Low price target$116.00
Upside to mean target+44.1%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)28.9
50-day MA$90.94
200-day MA$93.97
Price vs 50-day MA-9.9%
Price vs 200-day MA-12.8%
MACD histogram-0.29
Volume vs 3-month avg0.4×
52w low $67.6252w high $104.63

Analyst sentiment over time — IRMD

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-04-02

Latest call per bank · past 12 months

Recent rating actions

DateFirmActionRatingPrice target
2026-04-02Freedom BrokerInitiatesBuy$0.00 $116

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-09-11

  • RSI (14): RSI is 29 — oversold territory; selling pressure looks stretched.
  • Price vs 50-day MA: Trading 9.9% below the 50-day MA ($90.94).
  • Price vs 200-day MA: Trading 12.8% below the 200-day MA ($93.97).
  • MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • MACD (12,26,9): MACD histogram is negative (-0.29) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($67.62) and high ($104.63).

IRMD Price Chart

Loading chart for IRMD

Fundamentals

Revenue (TTM)$0M
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$7.96
Net Debt / EBITDA-2.0
WACC10.0%
Revenue growth0.00%
Earnings growth-9.00%

About iRadimed Corporation

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

More in Medical Devices

Screen IRMD against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.